FDA Approval Summary: Vemurafenib for the Treatment of...

  • Main
  • 2018 / 08
  • FDA Approval Summary: Vemurafenib for the Treatment of...
The Oncologist 2018 / 08

FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAF V600 Mutation

Oneal, Patricia A., Kwitkowski, Virginia, Luo, Lola, Shen, Yuan Li, Subramaniam, Sriram, Shord, Stacy, Goldberg, Kirsten B., McKee, Amy E., Kaminskas, Edvardas, Farrell, Ann, Pazdur, Richard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0295
Date:
August, 2018
File:
PDF, 161 KB
english, 2018
Conversion to is in progress
Conversion to is failed